China’s New Drug Procurement Program Shakes Up Big Pharma
The new bidding system for generic drugs upends the business of global drug makers in China. The big winners have been Chinese drug makers.
Delivering China’s Mail
How did USPS end up subsidizing China’s e-commerce?
China’s Solar Push
China makes most of the world’s solar panels. But its state policy banks seem reluctant to finance overseas solar projects. Why?
In the Tech Race, What Is the U.S. Doing to Get Ahead?
From public-private partnerships to CIA venture capital, a primer on the U.S. response to China.
Clouded Judgement
China’s cloud services are expected to balloon in coming years, but U.S. firms like Google, Amazon and Microsoft face tricky decisions about entering the market.
China Flexes Its Antitrust Law
As the U.S. and China escalate their tit-for-tat, both countries are looking for legitimacy under the cloak of the law.
Miniso’s Moment?
After a big NYSE debut, the Chinese retailer could face an uphill battle.
American Authors Get the Cold Shoulder in China
Once a growing market for U.S. books, China seems to have frozen the publishing pipeline.
Frayed Cables
With ‘Team Telecom’ monitoring undersea internet cables, U.S. connections to China aren’t getting any stronger.
China’s Semiconductor Future: What Can $1.4 Trillion Buy?
China’s semiconductor investment should be taken seriously, but perhaps not literally.
Are Chinese Drones a National Security Threat or Required for the National Interest?
The U.S. government can't seem to decide.
Coal Pushers
With a domestic glut, China is bankrolling coal projects abroad — even as the rest of the world cuts back.